This is a revenue compounding story with some multiple compression, not a
rerating fantasy. If Lemonade proves the 2026 profitability path, keeps car and pet growing, and raises cross-sell and retention, investors can underwrite it as a real
multi-line insurer with better operating leverage. That supports meaningful upside, but current expectations already embed a lot, so the likely win is strong compounding rather than a 10x outcome.